← All posts The Génie Talks

The last mile of a genome

By Abhishek Das · 13 Jul 2026 · 4 min read

A few years ago I watched a man hold his own genome and have no idea what he was looking at. He was standing in a clinic corridor with a thick report in both hands, turning pages dense with variant identifiers and reference ranges, and one word, in red, near the top. His clinician had thirty seconds and a document neither of them could really read together. He folded it back into its envelope. I would bet it is still in a drawer.

The last mile of a genome, slide 1 of 9 1 / 9

I am not a geneticist. I came into this field sideways, by standing next to people who are, and the first thing that struck me was how little of their rigor survives the trip to the person it is meant to help. The sequencing is extraordinary. The interpretation is careful. And then all of it is poured into a report built for the machine that produced it, and handed to someone with no way in.

That gap is the problem worth solving. Not the science. The last mile.

Two readers, one document

When we rebuilt our report, we started from a question that sounds obvious and is not. Who is actually going to read this? The answer is two people, and they are not the same person. There is the individual whose genome it is, who needs to see, on the first page, in plain language, what this means for them. And there is the clinician beside them, who needs, somewhere in the document, every marker and every gene laid out to be interrogated. For years the industry has handed both of them the same pages and hoped. It usually serves neither.

So the surface of our report is written for the person. Findings sort into four tendency zones, low to high. A tendency is a starting point, not a verdict. Genetics is one of three forces on the page, next to lifestyle and environment, and we say so plainly, because a high zone is an invitation to pay attention early, not a sentence passed. Every result points back toward a conversation with a qualified professional, not away from one.

Underneath that surface sits the annexure. Every trait mapped to its markers and its genes, with the counts shown. For the traits that are genuinely polygenic, coronary artery disease, type 2 diabetes, hypertension, that runs to hundreds of markers across dozens of genes. None of it is hidden from the clinician who wants to dig. The plain-language layer is not a replacement for the rigor. It sits on top of it.

The part a set of slides cannot hold

All of that is how we think a report should read. But here is the part that matters more, and the part I could only gesture at when we put this into a carousel. It is not our job to impose that reading on anyone.

Our actual specialisation is that the report bends. It carries the partner's brand, and the partner's choice of traits. Picture a cardiology group and a fertility centre. Same genotyping operation, same interpretation engine, two completely different documents in the hands of two different patients. The same machine underneath. A different report on top.

It would be easy to hear that as a cosmetic service. Skin the PDF, change the logo, send an invoice. That is not the interesting part, and if it were all we did, we would deserve to be compared on price and turnaround like any design shop. The interesting part is what trait selection actually buys.

Letting a partner decide which traits appear is how each report stays defensible in its own clinical context. Not every trait belongs in every report. A panel that is right for one setting is noise, or worse, in another. So the customisation is not decoration. It is editorial control, handed to the people who carry the clinical responsibility for what the report says.

That is also the honest answer to a question I get asked often. What do you actually cover? The truthful reply is that the question has no single answer, because the panel is not ours to fix once and for all. Our cardiometabolic work is deep, and I can defend it to a cardiologist. Beyond that, what ships is a decision made with the partner, for their patients, in their context. I think that is a feature, not an evasion, but I understand why it can sound like one, so I would rather say it directly.

What we are actually selling

The pitch, if it is a pitch, is not our taste. Taste is cheap and everyone has some. It is the combination that is hard to assemble elsewhere. A genotyping operation with more than ten thousand samples behind it. An interpretation engine we own and keep improving. And a reporting layer that puts both of those in service of whoever's name is on the page.

Customisation is how we deliver. It is not the value. The value is everything the customisation is riding on.

The engine is ours. The brand, and the science it chooses to show, are yours.

Want to see a sample report?

We'll walk you through what a patient sees, and what a clinician can dig into underneath.

Talk to our team

Abhishek Das, Co-Founder & CEO

Abhishek Das founded Genique Lifesciences in 2018. He holds a PGP from the Indian School of Business, reads widely and pontificates freely. He supports Arsenal and Argentina.

This article is for general and professional information. It is not medical advice, and does not recommend any test or treatment for any individual. Genique Lifesciences distributes genomics technologies and provides bioinformatics and sample-to-report services to institutions on a business-to-business basis; it does not provide clinical or diagnostic services to patients. Questions about testing for yourself or a family member should be raised with a treating clinician or a certified genetic counsellor.

Let's talk

Set up an introduction meeting today.

Tell us about your lab and where you want to take it. We'll bring the right technology and team.

Email contact@genique.co Phone +91 124-426-3051
Office Unit-805, 8th Floor, Unitech Arcadia, South City-2, Sector 49, Gurugram, Haryana 122018

By submitting this form you consent to Genique Lifesciences processing the details above to respond to your enquiry, and to their retention for 24 months from our last contact. You may withdraw consent at any time by emailing contact@genique.co. See our Privacy Policy.